Quellen:
Ostadal, Petr et al. “Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial.” Circulation, 10.1161/CIRCULATIONAHA.122.062949. 6 Nov. 2022, doi:10.1161/CIRCULATIONAHA.122.062949
https://pubmed.ncbi.nlm.nih.gov/36335478/
Metra, Marco et al. “Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.” European heart journal, ehac293. 22 May. 2022, doi:10.1093/eurheartj/ehac293
https://pubmed.ncbi.nlm.nih.gov/35675469/